Oxford Biodynamics is releasing its EpiSwitch Prostate Screening blood test in both the US and UK markets early, the company announced on 26 September.
The test will initially be available only through private channels. In the US, EpiSwitch Prostate tests will be processed at Oxford Biodynamics’ Clinical Laboratory Improvement Amendments (CLIA) certified laboratory based...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?